Watchlist Price Alert

Amneal Pharmaceuticals In... (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

7.75

-0.21 (-2.64%)

At close: Jun 13, 2025, 3:59 PM

7.75

-0.06%

After-hours: Jun 13, 2025, 04:04 PM EDT

Amneal Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	2.79B	2.39B	2.21B	2.09B	1.99B	1.63B	1.66B	1.03B	1.02B
Cost of Revenue	1.77B	1.53B	1.43B	1.31B	1.36B	1.27B	946.59M	507.48M	420.77M
Gross Profit	1.02B	820.57M	791.46M	783.95M	628.39M	353M	716.4M	526.18M	597.46M
Operating Income	249.33M	204.37M	-94.93M	152.72M	91.16M	-137.42M	-19.67M	245.1M	284.88M
Interest Income	n/a	n/a	158.38M	136.32M	n/a	168.21M	n/a	n/a	n/a
Pretax Income	-55.01M	-40.27M	-248.13M	31.37M	-35.78M	-220.24M	-202.72M	171.32M	214.82M
Net Income	-116.89M	-83.99M	-129.99M	10.62M	91.06M	-603.57M	-169.73M	167.65M	207.38M
Selling & General & Admin	476.44M	429.68M	399.7M	365.5M	326.73M	289.6M	230.44M	109.05M	118.76M
Research & Development	196.56M	194.75M	200.05M	209.56M	190.59M	202.29M	210.45M	191.94M	204.75M
Other Expenses	98.12M	18.74M	-3.96M	41.19M	19.93M	1.47M	2.85M	-47K	-669K
Operating Expenses	667.15M	659.5M	595.79M	616.26M	537.24M	491.88M	440.89M	300.98M	323.5M
Interest Expense	258.6M	210.63M	158.38M	136.32M	146M	168.21M	143.57M	71.06M	55.28M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.54B	2.19B	2.02B	1.94B	1.9B	1.77B	1.39B	808.46M	744.27M
Income Tax Expense	18.86M	8.45M	6.66M	11.2M	-104.36M	383.33M	-1.42M	2M	5.39M
Shares Outstanding (Basic)	308.98M	174.99M	150.94M	148.92M	149.28M	132.09M	127.25M	114.86M	114.86M
Shares Outstanding (Diluted)	308.98M	176.14M	150.94M	151.82M	148.91M	132.11M	127.25M	114.86M	114.86M
EPS (Basic)	-0.38	-0.48	-0.86	0.07	0.62	-4.57	-1.33	1.46	1.81
EPS (Diluted)	-0.38	-0.48	-0.86	0.07	0.61	-4.57	-1.33	1.46	1.81
EBITDA	439.77M	399.76M	150.43M	401.1M	345.61M	155.2M	-19.67M	271.13M	306.97M
EBIT	203.58M	170.36M	-89.75M	167.69M	110.22M	-52.04M	-59.15M	242.38M	270.1M
Depreciation & Amortization	236.19M	229.4M	240.18M	233.41M	235.39M	207.24M	137.4M	45.94M	33.02M